Your browser doesn't support javascript.
loading
Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP.
Hayden, Patrick J; Iacobelli, Simona; Pérez-Simón, José Antonio; van Biezen, Anja; Minnema, Monique; Niittyvuopio, Riitta; Schönland, Stefan; Meijer, Ellen; Blaise, Didier; Milpied, Noel; Márquez-Malaver, Francisco J; Veelken, Joan Hendrik; Maertens, Johan; Michallet, Mauricette; Cammenga, Jörg; N'Guyen, Stephanie; Niederwieser, Dietger; Hunault-Berger, Mathilde; Bourhis, Jean Henri; Passweg, Jakob; Bermudez, Arancha; Chalandon, Yves; Yakoub-Agha, Ibrahim; Garderet, Laurent; Kröger, Nicolaus.
Afiliación
  • Hayden PJ; Dept. of Haematology, Trinity College Dublin, St. James's Hospital, Dublin, Ireland.
  • Iacobelli S; Tor Vergata University of Rome, Rome, Italy.
  • Pérez-Simón JA; Hospital Universitario Virgen del Rocio, Instituto de Biomedicina y Universidad de Sevilla (IBIS)/CSIC/CIBERONC, Seville, Spain.
  • van Biezen A; Leiden EBMT Data Office, Leiden, Netherlands.
  • Minnema M; University Medical Centre Utrecht, Utrecht, Netherlands.
  • Niittyvuopio R; HUCH Comprehensive Cancer Center, Helsinki, Finland.
  • Schönland S; University of Heidelberg, Heidelberg, Germany.
  • Meijer E; VU University Medical Center, Amsterdam, Netherlands.
  • Blaise D; Centre de Recherche en Cancérologie de Marseille Institut Paoli Calmettes, Marseille, France.
  • Milpied N; CHU Bordeaux Hôpital Haut-leveque, Pessac, France.
  • Márquez-Malaver FJ; Hospital Universitario Virgen del Rocio, Instituto de Biomedicina y Universidad de Sevilla (IBIS)/CSIC/CIBERONC, Seville, Spain.
  • Veelken JH; Leiden University Medical Centre, Leiden, Netherlands.
  • Maertens J; University Hospital Gasthuisberg, Leuven, Belgium.
  • Michallet M; Centre Hospitalier Lyon-Sud, Lyon, France.
  • Cammenga J; Linköping University Hospital, Linköping, Sweden.
  • N'Guyen S; Hopital la Pitié-Salpêtrière, Paris, France.
  • Niederwieser D; University Hospital Leipzig, Leipzig, Germany.
  • Hunault-Berger M; CHRU Angers, Angers, France.
  • Bourhis JH; Gustave Roussy institut de cancérologie, Villejuif, France.
  • Passweg J; University Hospital of Basel, Basel, Switzerland.
  • Bermudez A; FEA Servicio de Hematología, Santander, Spain.
  • Chalandon Y; Hôpitaux Universitaires de Genève and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Yakoub-Agha I; Hôpital Claude Huriez, Lille, France.
  • Garderet L; Hospital Saint Antoine, Paris, France.
  • Kröger N; University Hospital Eppendorf, Hamburg, Germany.
Eur J Haematol ; 104(3): 181-189, 2020 Mar.
Article en En | MEDLINE | ID: mdl-31737951
ABSTRACT

OBJECTIVES:

The aim of this study was to compare the effect of the intensity of conditioning approaches used in allogeneic transplantation in myeloma-reduced intensity conditioning (RIC), non-myeloablative (NMA), myeloablative conditioning (MAC) or Auto-AlloHCT-on outcomes in patients who had had a prior autologous transplant.

METHODS:

A retrospective analysis of the EBMT database (1991-2012) was performed.

RESULTS:

A total of 344 patients aged between 40 and 60 years at the time of alloHCT were identified 169 RIC, 69 NMA, 65 MAC and 41 Auto-Allo transplants. At a median follow-up of 54 months, the probabilities of overall survival (OS) at 5 years were 39% (95% CI 31%-47%), 45% (95% CI 32%-57%), 19% (95% CI 6%-32%) and 34% (95% CI 17%-51%), respectively. Status at allogeneic HCT other than CR or PR conferred a 70% higher risk of death and a 40% higher risk of relapse. OS was markedly lower in the MAC group (P = .004). MAC alloHCT was associated with a higher risk of death than RIC alloHCT until 2002 (HR = 4.1, P < .001) but not after 2002 (HR = 1.2, P = .276).

CONCLUSION:

From 1991 to 2002, MAC was associated with poorer OS. Between 2003 and 2012, there were no significant differences in outcomes based on these different approaches.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Irlanda

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Irlanda